SynthesisThe Cochrane database of systematic reviews2025
Prognostic factors for return to work in breast cancer survivors.
Synthesis in The Cochrane database of systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prognostic factors for return to work in breast cancer survivors.The Cochrane database of systematic reviews · 2025Pooled it
- Return to work among self-employed breast cancer survivors from the CANTO cohort.Scientific reports · 2026Trial
- Return to work and work abandonment in female breast cancer survivors: systematic review and meta-analysis protocol.BMJ open · 2026Article
- EBCC-15 manifesto: Removing age-related barriers to improve equity in breast cancer care.Breast (Edinburgh, Scotland) · 2026Review
- Predictors of return-to-work adaptability in young breast cancer patients: A structural equation model analysis of individual resilience, self-perceived burden, and family resilience.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Return to work and cancer survivorship needs of breast cancer survivors: an observational prospective single-cohort study in Italy.Scientific reports · 2026Observational
- Return to Work After Breast Cancer Diagnosis and Treatment in Uruguay: Challenges and Determining Factors.Cureus · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast cancer is the most common type of cancer in women around the world. Large numbers of people diagnosed with breast cancer are working at the time of diagnosis. Accumulating evidence suggests that breast cancer survivors participate less often in paid work compared to others. Return to work among breast cancer survivors is multifactorial. It is currently unknown which factors are associated with return to work in breast cancer survivors. Therefore, it is important to systematically review and synthesize the literature on the association between sociodemographic, breast cancer-related, other health-related, personal, and work-related factors and return to work in this group of people.
objectivesThe objective is to systematically review and synthesize the literature on the association between sociodemographic, breast cancer-related, other health-related, personal, and work-related factors and return to work in the 24 months following breast cancer diagnosis among breast cancer survivors having paid work at the time of diagnosis. SEARCH
methodsThe search strategy included electronic searches in OVID/MEDLINE, Embase.com, EBSCOhost/CINAHL with Full Text, EBSCOhost/PsycINFO, Clarivate Analytics/Web of Science Core Collection and Wiley/Cochrane Library from inception up to 20 January 2023, as well as handsearching references of relevant reviews, included studies, and Google Scholar. SELECTION CRITERIA: The following inclusion criteria were applied: - The type of study is a prospective cohort study, retrospective cohort study with time lag between assessment of prognostic factor and outcome, or prognosis study based on a randomized controlled trial. - The study sample included people diagnosed with breast cancer, having paid work at the time of their breast cancer diagnosis. - At least one variable as specified in our variable framework was studied. - Return to work (yes/no), or time to return to work was assessed somewhere between one and 24 months of follow-up. - The article type is an original research article (commentaries, reviews, and editorials were excluded). - Full text of the article is available. - The article was published in a peer-reviewed journal. DATA COLLECTION AND ANALYSIS: Study characteristics and estimates of unadjusted and adjusted associations between one of the variables from the pre-defined variable framework and return to work were extracted. Risk of bias was assessed using the Quality in Prognosis Studies (QUIPS) tool. When at least four adjusted or four unadjusted measures of association (e.g. Odds Ratio (OR)) were available and more or less comparable in terms of how the measures of association were included in the analysis of the original study, a meta-analysis was conducted. MAIN
resultsThe systematic searches yielded 14,799 records with 2 identified via other sources. The systematic searches yielded 8486 references after duplicates were removed. We assessed 280 full-text articles for eligibility and excluded 249, including one article that was classified as 'awaiting classification' as it required professional translation. This left 31 articles based on 19 cohorts that fulfilled our inclusion criteria. Seven of the 19 studies could be included in one or more meta-analyses with a total of 2473 participants. All but one study were conducted in either Europe or the USA. The return to work rate ranged from 56% to 88%. From our prespecified variable framework, altogether 35 variables were studied in one or more included studies as prognostic factors. From these, we could combine five factors in the meta-analyses. - We found low-quality evidence that higher age is associated with lower odds of return to work in an adjusted analysis (pooled adjusted OR 0.96, 95% confidence interval (CI) 0.94 to 0.98; 4 studies, 1333 participants). - We found low-quality evidence that lower level of education is associated with lower odds of return to work in an unadjusted analysis (pooled unadjusted OR 0.40, 95% CI 0.29 to 0.55; 4 studies, 1680 participants), but not in an adjusted analysis (pooled adjusted OR 0.60, 95% CI 0.33 to 1.08; 4 studies, 1147 participants). - We found low-quality evidence that not having a partner is not associated with return to work in an unadjusted analysis (pooled unadjusted measures of association: 0.91 95% CI 0.67 to 1.23; 4 studies, 1680 participants). - We found low-quality evidence that receiving chemotherapy was associated with lower odds of return to work in an unadjusted analysis (pooled unadjusted measures of association: 0.48, 95% CI 0.31 to 0.73; 5 studies, 1766 participants). - We found low-quality evidence that receiving radiotherapy is not associated with return to work, respectively (pooled unadjusted measures of association: 1.03, 95% CI 0.64 to 1.17; 4 studies, 1680 participants). Due to the low number of included studies that measured the outcome, time to return to work, it was not possible to pool data of these studies. AUTHORS'
conclusionsWe found that higher age and receiving chemotherapy may be associated with lower odds of returning to work in breast cancer survivors (low-quality evidence; for chemotherapy, only pooled unadjusted results were available). Results regarding educational level are inconclusive. We furthermore found that there was no statistically significant adjusted association between having a partner and receiving radiotherapy (low-quality evidence; only unadjusted results were available). Further research is warranted to identify those breast cancer survivors who are at higher risk of not returning to work, so that they can receive timely support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.